Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration May 22, 2013 Partnership will accelerate the pace of discovery and innovation in Biomedical Sciences.
Ketamine Shows Significant Benefit in People with Treatment-Resistant Depression May 20, 2013 Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic.
Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice May 17, 2013 The study, led by James C. Iatridis, PhD, was published in the journal PLOS ONE on May 17.
Icahn School of Medicine at Mount Sinai and Bene Pharmachem Gmbh To Collaborate On Clinical Studies For Mucopolysaccharidoses May 15, 2013 The company, based in Germany, is the sole producer of pharmaceutical pentosan polysulfate.
Mount Sinai Researchers Identify Gene Mutations in Congenital Heart Disease May 12, 2013 Using high-throughput sequencing, an international research team including Mount Sinai discovers causes of severe congenital heart disease
Mount Sinai Honors Innovators in Scientific Research and Health Care Philanthropy at 2013 Commencement May 10, 2013 Nobel Prize-winner Daniel Kahneman, PhD, delivers keynote address and receives honorary degree
National Institute of Neurological Disorders and Stroke (NINDS) Stops Enrolling Patients in ARUBA Study Earlier than Planned May 10, 2013 Mount Sinai’s International Center for Health Outcomes and Innovation Research (InCHOIR) is the data-coordinating center for the trial
The Mount Sinai Medical Center Adopts HIPAA-Compliant Mobile Care App Across the Enterprise May 9, 2013 'Cureatr' App developed by Mount Sinai Hospital resident Dr. Joseph Mayer.
Children Living Near Toxic Waste Sites in Developing Countries May Experience Higher Blood Lead Levels Resulting in Lower IQ May 6, 2013 Mount Sinai researcher estimates that lead exposure could cause mental retardation in 6 in 1,000 children living near the sites.
Toxic Waste Sites Cause 'Healthy Years of Life Lost' for People Living in India, Philippines and Indonesia May 4, 2013 Mount Sinai researcher presents novel findings in environmental health at the Pediatric Academic Societies.
American Association of Clinical Endocrinologists (AACE) Announces New President: Mount Sinai's Jeffrey Mechanick, MD May 4, 2013 Mount Sinai researcher, Derek LeRoith, MD, receives distinction in Clinical Endocrinology Award at AACE’s Annual Scientific Sessions.
Mount Sinai Researchers Identify New Drug Target for Depression and Neuropathic Pain April 29, 2013 Increased levels of brain protein in response to antidepressants may lead to new therapies
Mount Sinai Enrolls 25,000 Patients for Its Landmark Biobank Program April 29, 2013 Unique genetic information takes electronic medical record to a more precise level.
Sarcoma Foundation of America Honors Robert G. Maki, MD, PhD, with the Nobility in Science Award April 29, 2013 Dr. Maki was recognized for his committment to finding a cure for sarcoma, a cancer of the connective tissue including bone, cartilage, muscle, and fat.
Inhibiting Enzymes in the Cell May Lead to Development and Proliferation of Cancer Cells April 25, 2013 Blocking certain enzymes in the cell may prevent cancer cell division and growth, according to new findings from researchers at Mount Sinai
Scientists at Mount Sinai Discover a Key Mechanism for the Most Common Form of Alzheimer's Disease April 25, 2013 Research identifies potential therapeutic targets for Late Onset Alzheimer's Disease (LOAD) by revealing a network of genes involved in the inflammatory response.
Cancer-Incidence Rates Higher Than Expected Among World Trade Center Rescue and Recovery Workers April 23, 2013 Comprehensive study by Mount Sinai’s WTC Health Program published in Environmental Health Perspectives.
Kenneth Davis, MD, President and CEO of The Mount Sinai Medical Center, Spoke on the Future of Medicine at the Aspen Ideas Festival Preview in New York City April 19, 2013 Mount Sinai will be the first medical center sponsor of the Aspen Ideas Festival.
Mount Sinai Launches Phase III Clinical Trial of Novel, Personalized Vaccine for Newly-Diagnosed Kidney Cancer April 17, 2013 Study will examine potential of investigational immunotherapy AGS-003 to improve survival when combined with standard kidney cancer treatment.
Mount Sinai Invents Gene Signature to Identify Individuals with Cirrhosis at High-Risk for Liver Cancer April 17, 2013 Mount Sinai researchers have developed the first gene test to identify patients with cirrhosis who are at highest risk of developing liver cancer.
